Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 168   

Articles published

GSK 1,465.94 +5.94 (0.41%)
price chart
GlaxoSmithKline plc (ADR)(GSK): A Big Pharma Stock With A Very Big Dividend
biotech Bob Ciura: Dividend stocks are abundant within the highly profitable health care and pharmaceutical sectors. But the biggest dividend among Big Pharma stocks belongs to GlaxoSmithKline PLC (NYSE:GSK). The Brentford, England-based company's ...
GlaxoSmithKline plc 7.1% Potential Upside Indicated by Citigroup  DirectorsTalk Interviews
Citigroup Inc. Reiterates Neutral Rating for GlaxoSmithKline plc (GSK)  Dakota Financial News
5 Dividend Darlings Delivering Jaw-Dropping Returns: GlaxoSmithKline plc ...
Fears over the financial robustness of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) were fanned in Wednesday business after it announced it was scrapping plans to return �4bn worth of cash to shareholders following its asset-swap with Novartis.
Why GlaxoSmithKline plc Is More Attractive Than HSBC Holdings plc
By traditional valuation ratios HSBC Holdings (LSE: HSBA) looks cheaper than GlaxoSmithKline (LSE: GSK), but there is more to successful long-term investing than buying the cheapest-looking shares.
5 Stocks David Cameron Should Consider Buying: GlaxoSmithKline plc, BP plc ...
Andrew Witty, chief executive of GlaxoSmithKline, is one of the chosen few, so it would seem logical for Mr Cameron to consider buying shares in the pharmaceuticals giant.
Why I Would Buy GlaxoSmithKline plc And Royal Mail PLC But Sell James ...
I believe that pills play GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is a terrific selection for those seeking a top-notch turnaround stock.
GlaxoSmithKline plc 1.2% Potential Upside Indicated by Credit Suisse
GlaxoSmithKline plc with EPIC LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'UNDERPERFORM' today by analysts at Credit Suisse.
GlaxoSmithKline plc Stock Rating Reaffirmed by Credit Suisse (GSK)  Dakota Financial News
GlaxoSmithKline plc's Underperform Rating Reiterated at Credit Suisse (GSK)  The Legacy
Better Dividend Stock: Pfizer, Inc. or GlaxoSmithKline plc?
Within the healthcare sector, Pfizer (NYSE: PFE ) and GlaxoSmithKline (NYSE: GSK ) are two popular dividend stocks because they have strong brands and a long history of paying out dividends, and they dole out a higher-than-average yield.
GlaxoSmithKline plc To Go Ex-Dividend on May 13th (GSK)  Dakota Financial News
GlaxoSmithKline: Out of step  Financial Times
GlaxoSmithKline plc 6.6% Potential Upside Indicated by Deutsche Bank
GlaxoSmithKline plc using EPIC code LON:GSK had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' today by analysts at Deutsche Bank.
GlaxoSmithKline plc Rating Reiterated by JPMorgan Chase & Co. (GSK)  Dakota Financial News
GlaxoSmithKline plc Receives Sell Rating from Societe Generale (GSK)  sleekmoney
3 Stocks That Should Keep Delivering The Goods: GlaxoSmithKline plc, Lloyds ...
News that GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is guaranteeing its dividend for three years was welcomed by the market, which feared the payout would be come under pressure due to falling earnings.
GlaxoSmithKline plc 4.6% Potential Upside Indicated by Deutsche Bank
GlaxoSmithKline plc using EPIC code LON:GSK had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' today by analysts at Deutsche Bank.
GlaxoSmithKline plc Receives "Underperform" Rating from BNP ...  sleekmoney
Weekly Research Analysts' Ratings Changes for GlaxoSmithKline plc (GSK)  Mideast Time